LOPHOS HOLDINGS INC.

Press Releases Lophos Holdings Inc.

Equities

MESC

CA5439371066

Delayed Canadian Securities Exchange Other stock markets 07:00:00 03/06/2024 pm IST			5-day change	1st Jan Change
0.05 ^CAD	0.00%		+25.00%	+25.00%

15/04	ThreeD Capital Inc. announced that it expects to receive CAD 0.1275 million in funding from Lophos Holdings Inc.	CI
15/04	ThreeD Capital Inc. entered into a securities purchase agreement to acquire 2.5% stake in Lophos Holdings Inc. for CAD 0.05 million.	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lophos Pharmaceuticals Corp. Receives Traditional Blessing for Napanee Site in Honor of Indigenous Heritage	15/05	NE
Lophos Pharmaceuticals Corp. Enters Into Letter of Intent to Acquire the Assets of Magicactus.com	06/05	AQ
Lophos Pharmaceuticals Corp. Commences Peyote Research Protocol	02/05	AQ
Lophos Pharmaceuticals Corp. Expands Peyote Cultivation with the Successful Planting of 3,000 Seeds	25/04	AQ
Lophos Pharmaceuticals’ Licensed Site Celebrates Successful Building Occupancy	17/04	AQ
ThreeD Capital Inc. and Lophos Holdings Inc. Announce Strategic Partnership	15/04	AQ
ThreeD Capital Inc. Announces Securities Purchase Agreement with Lophos Holdings Inc.	15/04	AQ
Lophos Holdings Inc. Celebrates Successful Conclusion of Inaugural Annual General Meeting, Confirms Board Members and Stock Options Plan	29/03	AQ
Lophos Pharmaceuticals Partners With Carmichael Engineering Ltd. for HVAC Project, Anticipates Expedited Building Occupancy	05/03	AQ
Lophos Confirms Appearance at Benzinga Capital Conference in Hollywood, Florida and Finalizes Annual General Meeting	28/02	AQ
Lophos Pharmaceuticals Corp. Finalizes the Development of a New Research Protocol for Lophophora Williamsii (Peyote)	14/02	AQ
Lophos Pharmaceuticals Corp. Finalizes the Development of a New Synthetic Mescaline Protocol	08/02	AQ
Lophos Pharmaceuticals Corp. Finalizes Product Release Specifications for Fresh and Dried Peyote (Lophophora williamsii)	31/01	AQ
Health Canada Endorses Lophophora Williamsii, Elevating Lophos Holdings Inc. as a Leader in Natural Health Innovation	23/01	AQ
Lophos Pharmaceuticals Corp. Receives Health Canada Approval for Expanded Controlled Substance Operations Following HVAC Revisions	22/11	AQ
Lophos Secures Game-Changing Controlled Substance Dealer's License with the Expertise of Canalytica Corp.	10/23/10	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+201.5% on SUPER MICRO COMPUTER since our purchase on February 17, 2023

Replicate our performance

fermer